Evidence map›Paper›PMID 25692764›Full record

ArticlePloS one2015

Traditional risk factors are more relevant than HIV-specific ones for carotid intima-media thickness (cIMT) in a Brazilian cohort of HIV-infected patients.

Antonio G Pacheco, Beatriz Grinsztejn, Maria de Jesus M da Fonseca, Ronaldo I Moreira, Valdiléa G Veloso, Ruth K Friedman, Marilia Santini-Oliveira, Sandra W Cardoso, Melissa Falcão, José G Mill and 3 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Antonio G PachecoFIOCRUZ, Programa de Computação Científica, Rio de Janeiro, Brazil.
Beatriz GrinsztejnFIOCRUZ, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
Maria de Jesus M da FonsecaFIOCRUZ, Departamento de Epidemiologia e Métodos Quantitativos em Saúde, Rio de Janeiro, Brazil.
Ronaldo I MoreiraFIOCRUZ, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
Valdiléa G VelosoFIOCRUZ, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
Ruth K FriedmanFIOCRUZ, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
Marilia Santini-OliveiraFIOCRUZ, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
Sandra W CardosoFIOCRUZ, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
Melissa FalcãoFIOCRUZ, Programa de Computação Científica, Rio de Janeiro, Brazil.
José G MillFederal University of Espírito Santo, Departamento de Ciências Fisiológicas, Vitória, Brazil.
Isabela BensenorUniversity of São Paulo, School of Medicine, São Paulo, Brazil.
Paulo LotufoUniversity of São Paulo, School of Medicine, São Paulo, Brazil.
Dóra ChorFIOCRUZ, Departamento de Epidemiologia e Métodos Quantitativos em Saúde, Rio de Janeiro, Brazil.

Funding

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)U01AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI GRINSZTEJN, BEATRIZ · 2008 to 2011
$14.0M
NIAID NIH HHS UM1 AI069476
6 · The paper itself

Abstract

backgroundCombination antiretroviral therapy (cART) had a dramatic impact on the mortality profile in human immunodeficiency virus (HIV) infected individuals and increased their life-expectancy. Conditions associated with the aging process have been diagnosed more frequently among HIV-infected patients, particularly, cardiovascular diseases.

methodsPatients followed in the Instituto de Pesquisa Clínica Evandro Chagas (IPEC) prospective cohort in Rio de Janeiro were submitted to the general procedures from the Brazilian Longitudinal Study of Adult Health, comprising several anthropometric, laboratory and imaging data. Carotid intima-media thickness (cIMT) was measured by ultrasonography, following the Mannheim protocol. Linear regression and proportional odds models were used to compare groups and covariables in respect to cIMT. The best model was chosen with the adaptive lasso procedure.

resultsA valid cIMT exam was available for 591 patients. Median cIMT was significantly larger for men than women (0.56mm vs. 0.53mm; p = 0.002; overall = 0.54mm). In univariable linear regression analysis, both traditional risk factors for cardiovascular diseases (CVD) and HIV-specific characteristics were significantly associated with cIMT values, but the best multivariable model chosen included only traditional characteristics. Hypertension presented the strongest association with higher cIMT terciles (OR = 2.51; 95%CI = 1.69-3.73), followed by current smoking (OR = 1,82; 95%CI = 1.19-2.79), family history of acute myocardial infarction or stroke (OR = 1.60; 95%CI = 1.10-2.32) and age (OR per year = 1.12; 95%CI = 1.10-1.14).

conclusionsOur results show that traditional cardiovascular disease (CVD) risk factors are the major players in determining increased cIMT among HIV infected patients in Brazil. This finding reinforces the need for thorough assessment of those risk factors in these patients to guarantee the incidence of CVD events remain under control.

Indexed as

AdultBrazilCardiovascular DiseasesCarotid Intima-Media ThicknessFemaleHIV InfectionsHumansMaleMiddle AgedProspective StudiesRisk Factors

Identifiers

PMID25692764
PMCPMC4333203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.